PMID: 16524355Mar 10, 2006Paper

Challenges and obstacles in measuring outcomes

The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
Guido R Zanni

Abstract

Numerous factors contribute to the need for consultant pharmacists to understand and measure outcomes. Consumer groups, legislatures, regulatory and certification agencies, among others, are interested in this information. The science of quality improvement is still young. Distinguishing among three terms--quality indicators, quality measures, and benchmarks--is easy enough once they become familiar. The roots of most long-term care quality models rest on the Donabedian model. Care is necessary when selecting outcomes measures because several pitfalls exist. When carefully selected, outcomes measures can improve care immensely and decrease the risk of adverse events.

References

Nov 3, 1988·The New England Journal of Medicine·W L RoperH Krakauer
Sep 14, 2000·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·C HarringtonP Beutel
Apr 25, 2003·The Gerontologist·Vincent MorTerry Moore
Feb 24, 2004·The Gerontologist·Marilyn J RantzMeridean Maas
Mar 23, 2004·Health Services Research·John F SchnelleBarbara M Bates-Jensen
Nov 19, 2004·Journal of Managed Care Pharmacy : JMCP·Frederic R Curtiss
Apr 1, 2005·The Gerontologist·Greg ArlingChristine Mueller
Apr 9, 2005·Journal of the American Geriatrics Society·Dan R BerlowitzDana B Mukamel
May 14, 2005·Journal of the American Medical Directors Association·Debra SalibaNeil Wenger
May 17, 2005·Journal of the American Medical Directors Association·Robert L AbelCarol McCauley
Sep 15, 2005·Statistics in Medicine·Jason Roy, Vincent Mor
Oct 6, 2005·The Milbank Quarterly·Vincent Mor

❮ Previous
Next ❯

Citations

Aug 14, 2009·Journal of Evaluation in Clinical Practice·Vahé Kazandjian
Sep 16, 2010·British Journal of Clinical Pharmacology·Norul Badriah HassanAbdul Rashid Abdul Rahman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
Seth W GlickmanKevin A Schulman
Medicina intensiva
M C MartínGrupos de trabajo de la Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias (SEMICYUC), Sociedad Española
© 2021 Meta ULC. All rights reserved